Oral capsule medication has not changed much since its inception in the 17th century. While taking this type of medication is suitable for many health conditions, some conditions require a more personalised approach – A recent report showed that over 1.3% million people suffer from inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. In such gut conditions, technology is bringing a new shift to the way people can leverage medication resources.
Smarttab is a modern medical health solution which one can use to deliver controlled amounts of medication to patients in specific areas of their gut. The user has to ingest the pill, which contains the appropriate medication.
The technology works through radio frequency signalling with an onboard smart chip. This ensures it can provide a highly effective release of drugs with precision, i.e. pinpointed to the area with inflammation in the gut. This helps reduce side effects and can help obtain better control of symptoms. Plus, the capsule features an onboard sensor, which doctors can use to acquire data on how to optimise treatment. A user can connect the Smarttab to a smartphone using Bluetooth.
The Smartab does not contain any batteries and harnesses wireless power. Once ingested, it can remain in the bowel system for up to a week before passing through the stool. The technology is safe to use and does not have any longer-term side effects. Additionally, the company is also performing further research on improving the benefits of this drug. Future products include a capsule that can inject itself at a specific location in the gut. This would allow medications that typically require an injection to be taken simply with water.